Hameln Pharma Ltd

Information

Name

Hameln Pharma Ltd

Type

Company

Roles

Supplier

Company Size

Sme

Company Number

Incorporation Date

Website

http://www.hameln.co.uk

Address

Unit C, Nexus, Gloucester Business Park,

Gloucester, Gloucestershire,
GL3 4AG
United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Hameln Pharma Ltd
Sign up free

Contracts awarded to Hameln Pharma Ltd

The contracts that Hameln Pharma Ltd have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 1 month ago

Generic, Branded Generic & Proprietary Medicinal Products - Group 14

Generic, Branded Generic & Proprietary Medicinal Products - Group 14 (5190931)

£10,725,841
Award

Published 4 months ago

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)

£424,035,364 Bids close: 9 months ago
Award

Published 4 months ago

NP36124 Antibiotic, Antiviral & Genito Urinary Medicines

Supply of Antibiotic, Antiviral & Genito Urinary Medicines to NHS Scotland.

£29,647,268
Award

Published 5 months ago

NHS National Generic Pharmaceuticals Wave 14c

NHS National Generic Pharmaceuticals- Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)

£219
Award

Published 6 months ago

NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines

This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

£33,081,281
Award

Published 7 months ago

Generic, Branded Generic & Proprietary Medicinal Products - Group 13

Generic, Branded Generic & Proprietary Medicinal Products - Group 13 (4844244)

£13,838,930

Contacts

+44 1452621661

Statistics (1 Year)

Contracts Won

Total Won

£71,217,167

Average Win

£17,804,292

Hameln Pharma Ltd

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Hameln Pharma Ltd

Generic, Branded Generic & Proprietary Medicinal Products - Group 14

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

NP36124 Antibiotic, Antiviral & Genito Urinary Medicines

NHS National Generic Pharmaceuticals Wave 14c

NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines

Generic, Branded Generic & Proprietary Medicinal Products - Group 13

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win